Efficacy Testing (PT18 / PT19)

Robust efficacy data is required for approval, which may include various test designs depending on the product and claim, e.g., laboratory, simulated-use, or field studies. BioGenius conducts these studies according to relevant requirements (including BPR, EPA, WHO, and other international specifications) and assists in selecting suitable test strategies. Since the specific requirements depend heavily on the application case, early coordination to define a regulatorily sound study design is advisable.

In addition to regulatory studies, BioGenius also offers screening, development, and comparative tests that can be specifically used to substantiate product claims. These include, for example, dose-response tests, barrier or repellent effects, and investigations into the “secondary kill” effect. This allows for the derivation of well-founded statements for product positioning and marketing, based on valid and reproducible data.

BioGenius covers a wide range of application forms, including sprays, vaporizers, foggers, baits, and treated materials. Tests can be carried out as direct application, as spatial effect (e.g., for aerosols or vaporizers), or as surface treatment. Additionally, various test environments are available, from small units to larger test rooms, to replicate realistic application scenarios.

Yes, efficacy tests can be linked with analytical investigations, e.g., to determine the active ingredient concentration during application, to analyze residues, or to evaluate degradation processes. This combination enables a deeper understanding of product performance and supports both product development and the creation of consistent and regulatorily sound data packages.

In such cases, BioGenius examines the feasibility of individual test approaches and, if necessary, develops adapted or new testing methods. This also includes the evaluation of special application conditions and the coordination of suitable study designs within the framework of technical consulting. The goal is to generate valid efficacy data even for innovative or complex products that meet both regulatory and market-specific requirements.